Crossmark

Notch pathway defines an aggressive and immune-suppressive phenotype associated with checkpoint inhibitor resistance in pan-gastrointestinal adenocarcinomas

Crossref DOI link: https://doi.org/10.1007/s10238-025-01825-6

Published Online: 2025-10-31

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Luo, Yang

Wang, Roushu

Xu, Yu

He, Mengjiang

Zhou, Qiaoxia

Wang, Guoqiang

Ye, Guangyao

Xu, Chunwei

Wang, Wenxian

Cai, Shangli

Peng, Feng

Zhu, Xu
License Information

Text and Data Mining valid from 2025-10-31

Version of Record valid from 2025-10-31
More Information

Article History

Received: 26 May 2025

Accepted: 18 July 2025

First Online: 31 October 2025

Declarations

:

: The authors declare no competing interests.

: The clinical data analyzed in the present study were retrieved from public cohorts, and therefore ethics approval and consent are not necessary.

: Not applicable.

Document is current

Any future updates will be listed below